Titre : Azépines

Azépines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ventricular Function, Left
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Azépines : Questions médicales les plus fréquentes", "headline": "Azépines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Azépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-14", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Azépines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétéromonocycliques", "url": "https://questionsmedicales.fr/mesh/D006573", "about": { "@type": "MedicalCondition", "name": "Composés hétéromonocycliques", "code": { "@type": "MedicalCode", "code": "D006573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dilazep", "alternateName": "Dilazep", "url": "https://questionsmedicales.fr/mesh/D004109", "about": { "@type": "MedicalCondition", "name": "Dilazep", "code": { "@type": "MedicalCode", "code": "D004109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.200" } } }, { "@type": "MedicalWebPage", "name": "Meptazinol", "alternateName": "Meptazinol", "url": "https://questionsmedicales.fr/mesh/D008621", "about": { "@type": "MedicalCondition", "name": "Meptazinol", "code": { "@type": "MedicalCode", "code": "D008621", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.400" } } }, { "@type": "MedicalWebPage", "name": "Oxazépines", "alternateName": "Oxazepines", "url": "https://questionsmedicales.fr/mesh/D010077", "about": { "@type": "MedicalCondition", "name": "Oxazépines", "code": { "@type": "MedicalCode", "code": "D010077", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.498" } } }, { "@type": "MedicalWebPage", "name": "Pentétrazol", "alternateName": "Pentylenetetrazole", "url": "https://questionsmedicales.fr/mesh/D010433", "about": { "@type": "MedicalCondition", "name": "Pentétrazol", "code": { "@type": "MedicalCode", "code": "D010433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Azépines", "alternateName": "Azepines", "code": { "@type": "MedicalCode", "code": "D001381", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peng An", "url": "https://questionsmedicales.fr/author/Peng%20An", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Ranran Li", "url": "https://questionsmedicales.fr/author/Ranran%20Li", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Bin Zhang", "url": "https://questionsmedicales.fr/author/Bin%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Yi-Kang Zhang", "url": "https://questionsmedicales.fr/author/Yi-Kang%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Sylvian Cretton", "url": "https://questionsmedicales.fr/author/Sylvian%20Cretton", "affiliation": { "@type": "Organization", "name": "Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Association of arterial properties with left ventricular morphology and function in the community.", "datePublished": "2022-08-18", "url": "https://questionsmedicales.fr/article/35983866", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/HJH.0000000000003272" } }, { "@type": "ScholarlyArticle", "name": "Effect of Corticosteroids on Left Ventricular Function in Patients With Cardiac Sarcoidosis.", "datePublished": "2022-06-11", "url": "https://questionsmedicales.fr/article/35701237", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjcard.2022.04.051" } }, { "@type": "ScholarlyArticle", "name": "Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.", "datePublished": "2023-11-07", "url": "https://questionsmedicales.fr/article/37935592", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/14767058.2023.2279018" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of left ventricular systolic function in patients with iron deficiency anemia based on non-invasive left ventricular pressure-strain loops.", "datePublished": "2024-08-17", "url": "https://questionsmedicales.fr/article/39152411", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12938-024-01276-2" } }, { "@type": "ScholarlyArticle", "name": "Left Atrial Strain for Assessment of Left Ventricular Diastolic Function: Focus on Populations With Normal LVEF.", "datePublished": "2023-01-11", "url": "https://questionsmedicales.fr/article/36752445", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcmg.2022.10.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Azépines", "item": "https://questionsmedicales.fr/mesh/D001381" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Azépines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Azépines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Azépines", "description": "Comment diagnostiquer un trouble d'anxiété ?\nQuels tests sont utilisés pour évaluer l'anxiété ?\nLes azépines sont-elles prescrites pour d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nComment différencier l'anxiété normale de l'anxiété pathologique ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Azépines", "description": "Quels sont les symptômes courants de l'anxiété ?\nLes azépines peuvent-elles provoquer des effets secondaires ?\nComment l'anxiété se manifeste-t-elle physiquement ?\nQuels signes indiquent une crise d'angoisse ?\nLes symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Azépines", "description": "Comment prévenir les troubles anxieux ?\nLes techniques de relaxation sont-elles efficaces ?\nL'éducation sur l'anxiété peut-elle aider ?\nLe soutien social joue-t-il un rôle dans la prévention ?\nLes azépines peuvent-elles être utilisées en prévention ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Azépines", "description": "Comment les azépines agissent-elles sur l'anxiété ?\nQuels sont les principaux azépines prescrites ?\nLes azépines sont-elles addictives ?\nComment se déroule un traitement avec azépines ?\nLes azépines peuvent-elles être combinées avec d'autres traitements ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Azépines", "description": "Quelles complications peuvent survenir avec les azépines ?\nLes azépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les risques d'un sevrage brutal ?\nLes azépines peuvent-elles affecter la mémoire ?\nComment gérer les complications liées aux azépines ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Azépines", "description": "Quels sont les facteurs de risque pour l'anxiété ?\nL'âge influence-t-il le risque d'anxiété ?\nLe sexe joue-t-il un rôle dans l'anxiété ?\nLes antécédents médicaux augmentent-ils le risque ?\nLe mode de vie peut-il influencer l'anxiété ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Ventricular+Function,+Left&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble d'anxiété ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation des symptômes et l'exclusion d'autres troubles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'anxiété ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles d'évaluation psychologique et des entretiens cliniques sont utilisés." } }, { "@type": "Question", "name": "Les azépines sont-elles prescrites pour d'autres troubles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour les troubles du sommeil et les crises d'angoisse." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la durée des symptômes et leur impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Comment différencier l'anxiété normale de l'anxiété pathologique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété pathologique est persistante, excessive et interfère avec le fonctionnement quotidien." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'anxiété ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'inquiétude excessive, l'irritabilité et les troubles du sommeil." } }, { "@type": "Question", "name": "Les azépines peuvent-elles provoquer des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme la somnolence, la confusion et des troubles de la mémoire peuvent survenir." } }, { "@type": "Question", "name": "Comment l'anxiété se manifeste-t-elle physiquement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des palpitations, des tremblements et des douleurs musculaires." } }, { "@type": "Question", "name": "Quels signes indiquent une crise d'angoisse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une peur intense, des palpitations, des sueurs et des sensations d'étouffement." } }, { "@type": "Question", "name": "Les symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en intensité et en type selon les individus." } }, { "@type": "Question", "name": "Comment prévenir les troubles anxieux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La gestion du stress, l'exercice régulier et une bonne hygiène de vie peuvent aider." } }, { "@type": "Question", "name": "Les techniques de relaxation sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la méditation et le yoga peuvent réduire l'anxiété." } }, { "@type": "Question", "name": "L'éducation sur l'anxiété peut-elle aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre l'anxiété et ses mécanismes peut aider à mieux la gérer." } }, { "@type": "Question", "name": "Le soutien social joue-t-il un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon réseau de soutien social peut réduire le risque de troubles anxieux." } }, { "@type": "Question", "name": "Les azépines peuvent-elles être utilisées en prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont généralement pas recommandées pour la prévention en raison du risque de dépendance." } }, { "@type": "Question", "name": "Comment les azépines agissent-elles sur l'anxiété ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles augmentent l'effet du GABA, un neurotransmetteur inhibiteur, réduisant ainsi l'anxiété." } }, { "@type": "Question", "name": "Quels sont les principaux azépines prescrites ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les principales incluent le diazépam, le lorazépam et l'alprazolam." } }, { "@type": "Question", "name": "Les azépines sont-elles addictives ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation prolongée peut entraîner une dépendance et un sevrage difficile." } }, { "@type": "Question", "name": "Comment se déroule un traitement avec azépines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement commence généralement par une faible dose, ajustée selon la réponse du patient." } }, { "@type": "Question", "name": "Les azépines peuvent-elles être combinées avec d'autres traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être combinées avec des thérapies cognitivo-comportementales pour une efficacité accrue." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les azépines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dépendance, le sevrage et des troubles cognitifs." } }, { "@type": "Question", "name": "Les azépines peuvent-elles interagir avec d'autres médicaments ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec des antidépresseurs et des analgésiques, augmentant les risques." } }, { "@type": "Question", "name": "Quels sont les risques d'un sevrage brutal ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un sevrage brutal peut entraîner des symptômes graves comme des convulsions et des hallucinations." } }, { "@type": "Question", "name": "Les azépines peuvent-elles affecter la mémoire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des troubles de la mémoire, surtout à forte dose ou sur le long terme." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux azépines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut une réduction progressive de la dose et un suivi médical régulier." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour l'anxiété ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le stress, les antécédents familiaux et des événements traumatiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'anxiété ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes et les personnes âgées sont souvent plus à risque." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans l'anxiété ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont généralement plus susceptibles de souffrir de troubles anxieux que les hommes." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de dépression ou de troubles mentaux augmentent le risque d'anxiété." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer l'anxiété ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Association of arterial properties with left ventricular morphology and function in the community.

Arterial structural and functional remodeling is recognized as a key determinant of incident heart failure, although the contribution of arterial properties on left ventricular (LV) remodeling is not ... The study cohort consisted of 539 participants without overt cardiac disease who underwent extensive cardiovascular examination. Aortic root diameter was measured by two-dimensional echocardiography a... Aortic root diameter and ePWV were correlated with LV mass index and LVGLS, while only ePWV was related to E / e' ratio. In multivariable analysis, aortic root diameter and ePWV were significantly rel... Aortic root size and ePWV were independently associated with unfavorable LV remodeling in individuals free of cardiac disease, which might provide useful information into the pathogenesis-linking arte...

Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.

Peripartum cardiomyopathy (PPCM) is a rare type of cardiomyopathy that manifests as acute heart failure associated with pregnancy. Delays in early identification result in poor recovery of left ventri... All baseline and clinical parameters were prospectively collected from a cohort of patients with PPCM admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia between January 2014 and Dece... This prospective cohort study included 113 patients with PPCM (84 recovered and 29 non-recovered patients). Significant mitral regurgitation (MR), left ventricular ejection fraction (LVEF) <30%, left ... PPCM recovery score is a convenient scoring system based on clinical and echocardiography assessment that may assist in distinguishing which patients are more likely to develop poor LV function recove...

Evaluation of left ventricular systolic function in patients with iron deficiency anemia based on non-invasive left ventricular pressure-strain loops.

Iron deficiency anemia (IDA) is a common health problem worldwide. The objective of this study was to noninvasively and quantitatively evaluate early changes in left ventricular systolic function in p... Sixty-two patients with IDA were selected and divided into two groups based on hemoglobin (Hb) concentration: Group B with Hb > 9 g/dL and group C with 6 g/dL < Hb < 9 g/dL. Thirty-three healthy indiv... Compared to group A, GWI and GCW were reduced in group B (both P < 0.01). Compared with groups B and A, GLS, GWI, GCW and GWE, and E/A were all diminished, and GWW, LVEDV, LVESV, and E/mean e' were al... LV-PSL allows noninvasive quantitative assessment of early impaired LV systolic function in IDA patients with preserved LV ejection fraction, and GWI has high sensitivity and specificity compared with...

Association between spirometry pattern, left ventricular diastolic function, and mortality.

Spirometric abnormalities have been related to incident heart failure in general population, who generally have preserved left ventricular ejection fraction (LVEF). We aimed to investigate the associa... Subjects presenting with exertional dyspnoea and received spirometry and echocardiography were eligible for this study. Forced vital capacity (FVC) and forced expiratory volume in the first second (FE... Among a total of 8669 participants (65.8 ± 16.3 years, 56% men), 3739 (43.1%), 829 (9.6%), 3050 (35.2%) and 1051 (12.1%) had normal, obstructive, restrictive and mixed spirometry pattern, respectively... The restrictive spirometry pattern or the declined FVC was associated with left ventricular diastolic dysfunction, which aggravated the long-term mortality in the ambulatory dyspnoeic subjects....

Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.

Coronary microvascular dysfunction (CMD) has been proposed as an important pathophysiological mechanism in Takotsubo syndrome (TTS). Our aims were (i) to evaluate and compare levels of CMD in patients... We conducted a prospective study of 27 female TTS patients and an equally sized, age- and gender-matched, cohort of INOCA patients. Coronary microvascular function was quantified invasively using the ... Coronary microvascular dysfunction is common in patients with TTS and more frequent than in patients with INOCA. CMD in TTS is more severe in the apical compared with the midventricular phenotype of t...

Assessment of left ventricular structure and function in preeclampsia subtypes by multimodal echocardiography.

To explore left ventricular structural/functional abnormalities in preeclampsia patients by using multimodal echocardiography and to analyze the cardiac impact in preeclampsia subtypes.... A total of 103 individuals, including 64 preeclampsia patients and 39 healthy pregnant women were recruited for this study from 2019 to 2021. There were 34 patients with preeclampsia with severe featu... EO-SPE patients showed decreased left ventricular ejection fractions, peak longitudinal systolic strain at apical four-chambers, peak circumferential, and radial systolic strain at the apical and mitr... EO-SPE patients were characterized by left ventricular injury and systolic function reduced. LO-SPE patients were characterized by left ventricular hypertrophy and reduced diastolic function. Multimod...